Volcano Corp. has announced it will acquire Sync-Rx, according to a news release.
Sync-Rx is an Israel-based developer of software applications designed to optimize and facilitate transcatheter cardiovascular interventions using automated online image processing.
Industry reports put the acquisition price at about $17.3 million.
"This transaction represents a strategic step in the advancement of our multi-modality platform," said Scott Huennekens, president and CEO of Volcano Corp., in the release. "Sync-Rx's technology provides Volcano with a platform on which to build a range of advanced software features that will aid clinical decision-making by providing angiography and intra-body image enhancement, measurements and non-invasive imaging and intravascular co-registration capabilities, and future opportunities in physiology and peripheral and minimally invasive structural heart therapy guidance. We are excited about the Sync-Rx team joining Volcano and establishing a footprint in Israel, given the breadth and depth of medical imaging and software talent there."
The transaction is expected to close within the next 30 days.
Volcano Corp. is headquartered in San Diego.
Related Articles on Company Acquisitions:
Baxter Close to Acquiring Gambro for $4 Billion
Alcon Acquires Ophthalmic Division of Sensomotoric Instruments
Wright Medical to Acquire BioMimetic Therapeutics